Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Dual eligibles with mental disorders and Medicare part D: how are they faring?

Donohue JM, Huskamp HA, Zuvekas SH.

Health Aff (Millwood). 2009 May-Jun;28(3):746-59. doi: 10.1377/hlthaff.28.3.746.

2.

Saying no isn't NICE - the travails of Britain's National Institute for Health and Clinical Excellence.

Steinbrook R.

N Engl J Med. 2008 Nov 6;359(19):1977-81. doi: 10.1056/NEJMp0806862. No abstract available.

3.

What explains the diffusion of treatments for mental illness?

Drake R, Skinner J, Goldman HH.

Am J Psychiatry. 2008 Nov;165(11):1385-92. doi: 10.1176/appi.ajp.2008.08030334. No abstract available.

4.

Key factors for implementing supported employment.

Marshall T, Rapp CA, Becker DR, Bond GR.

Psychiatr Serv. 2008 Aug;59(8):886-92. doi: 10.1176/ps.2008.59.8.886.

PMID:
18678686
5.

The "3T's" road map to transform US health care: the "how" of high-quality care.

Dougherty D, Conway PH.

JAMA. 2008 May 21;299(19):2319-21. doi: 10.1001/jama.299.19.2319. No abstract available.

PMID:
18492974
6.

Lessons to take home from CATIE.

Carpenter WT, Buchanan RW.

Psychiatr Serv. 2008 May;59(5):523-5. doi: 10.1176/ps.2008.59.5.523.

PMID:
18451009
7.

Policy toward second-generation antipsychotic drugs: a cautionary note.

Frank RG.

Psychiatr Serv. 2008 May;59(5):521-2. doi: 10.1176/ps.2008.59.5.521. No abstract available.

PMID:
18451008
8.

Second-generation antipsychotics: cost-effectiveness, policy options, and political decision making.

Rosenheck RA, Leslie DL, Doshi JA.

Psychiatr Serv. 2008 May;59(5):515-20. doi: 10.1176/ps.2008.59.5.515.

PMID:
18451007
9.

Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials.

Correll CU, Rummel-Kluge C, Corves C, Kane JM, Leucht S.

Schizophr Bull. 2009 Mar;35(2):443-57. doi: 10.1093/schbul/sbn018. Epub 2008 Apr 15.

10.

QUALITY-CONSTANT "PRICES" FOR THE ONGOING TREATMENT OF SCHIZOPHRENIA: AN EXPLORATORY STUDY*

Frank RG, Berndt ER, Busch AB, Lehman AF.

Q Rev Econ Finance. 2004 Jul;44(3):390-409.

11.

Antipsychotic polypharmacy trends among Medicaid beneficiaries with schizophrenia in San Diego County, 1999-2004.

Gilmer TP, Dolder CR, Folsom DP, Mastin W, Jeste DV.

Psychiatr Serv. 2007 Jul;58(7):1007-10.

PMID:
17602020
12.

The state policy context of implementation issues for evidence-based practices in mental health.

Isett KR, Burnam MA, Coleman-Beattie B, Hyde PS, Morrissey JP, Magnabosco J, Rapp CA, Ganju V, Goldman HH.

Psychiatr Serv. 2007 Jul;58(7):914-21.

PMID:
17602006
13.

Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach.

Wu EQ, Shi L, Birnbaum H, Hudson T, Kessler R.

Psychol Med. 2006 Nov;36(11):1535-40. Epub 2006 Aug 15.

PMID:
16907994
14.

The economic burden of schizophrenia in the United States in 2002.

Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M, Aggarwal J.

J Clin Psychiatry. 2005 Sep;66(9):1122-9.

PMID:
16187769
15.

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators.

N Engl J Med. 2005 Sep 22;353(12):1209-23. Epub 2005 Sep 19. Erratum in: N Engl J Med. 2010 Sep 9;363(11):1092-3.

16.

A systematic review of the prevalence of schizophrenia.

Saha S, Chant D, Welham J, McGrath J.

PLoS Med. 2005 May;2(5):e141. Epub 2005 May 31. Review.

17.

Medicaid policies to contain psychiatric drug costs.

Koyanagi C, Forquer S, Alfano E.

Health Aff (Millwood). 2005 Mar-Apr;24(2):536-44. Review.

18.

Comparison of clozapine use in Maryland and in Victoria, Australia.

Conley RR, Kelly DL, Lambert TJ, Love RC.

Psychiatr Serv. 2005 Mar;56(3):320-3.

PMID:
15746507
19.

Patterns and quality of treatment for patients with schizophrenia in routine psychiatric practice.

West JC, Wilk JE, Olfson M, Rae DS, Marcus S, Narrow WE, Pincus HA, Regier DA.

Psychiatr Serv. 2005 Mar;56(3):283-91.

PMID:
15746502
20.

Revised PORT recommendations.

Stroup TS, McEvoy JP, Lieberman JA.

Schizophr Bull. 2004;30(3):609-11. No abstract available.

PMID:
15631251

Supplemental Content

Support Center